New drug SAR444336 takes first step in human safety trial
NCT ID NCT05876767
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This early-phase study tested a new investigational drug called SAR444336 in 76 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo as a single or repeated injection. The goal was to gather safety data before moving on to test the drug in patients with a disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SAR444336
What this could lead to
If this drug is safe, it could be tested in patients with certain diseases to see if it helps.
What could go wrong
This is a very early phase 1 study in only 76 healthy people. It is designed to check safety, not effectiveness. The drug may not work or may have side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number :5280001
Leiden, Leiden, 2333 CL, Netherlands
-
Investigational Site Number :5280002
Groningen, Provincie Groningen, 9728 NZ, Netherlands